RxDoctor Payments Data

Alejandro Perez Torres, MD

Ophthalmology · Ponce, PRNPI 1467980458

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 25.2% of the total. Reporting peaked in 2024 at $524 and has fallen 68.1% since, to $167 in 2025.

$1,288in general payments, 2019–2025

Across 28 payments — averaging $45.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$325
  • Alcon Puerto Rico Inc$253
  • Apellis Pharmaceuticals, Inc.$237
  • Johnson & Johnson Surgical Vision, Inc.$205
  • AbbVie$193
  • Tarsus Pharmaceuticals, Inc.$28
  • plus $46 from 2 others

What the payments were for

  • Food & beverage$1,288100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,288 in reported general payments places this provider in the 65th percentile of 214 ophthalmology providers in Puerto Rico.

See all ophthalmology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024
$23,839
Medicare patients
19
Services billed
415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate11$557
Brimonidine Tartrate14$115

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Ponce

See the full list for Puerto Rico →

Where these figures come from

Is this you, or does something look wrong? →